indegeneWhite.main

Let’s partner for #FutureReadyHealthcare

newThemeh2

Drive commercial success through innovation and creativity

Emerging Biotech CEO Council

newThemeh1

The council is focused on creating a forum for open dialogue and game-changing conversations that drive growth and commercial success for biotech organizations. 

indegeneBlack.main

Mission

newThemeBody1

Council membership provides an opportunity for C-suite executives to network, share issues and solutions with each other, and work together to creatively rethink strategies and capabilities.

Vision

What drives us

newThemeh3

The Emerging Biotech CEO Council is a group of visionary CEOs from emerging biotech companies who meet regularly to connect, collaborate, and learn from each other.

Who we are

Back to Industry Councils

body1

primary.main

Brad Bailey

newThemeBody12

Dan Brennan

Jeff Christensen

Vic Clavelli

Rich Daly

Patrick Gallagher

John Glasspool

Kate Hermans

Ed Jordan

Sarah Liu

Sanjeev Luther

Narasimhan Mani

Shane Shaffer

Farrell Simon

Vineet Singhal

Raul Trillo

2.7rem

newThemeh4

The Digitally-Savvy HCP​

newThemeh5

Carlyle and Brighton Park agree to invest US $200 million in Indegene​

Indegene Digital Summit 2020 Highlights

Resources

Manish Gupta

The emerging biotech council is a place for leaders from emerging biopharma companies to connect, collaborate, and learn from each other and drive commercial success for their organizations.

We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready.

We are a digital-first, life sciences commercialization company

What we do

Build a trusted and confidential environment for leaders from emerging biopharma enterprises to connect and collaborate on innovation and spur commercial success

To enable emerging biopharma enterprises to jointly discover ways to re-think capabilities, leverage innovative business models, and reduce reliance on traditional systems

The Emerging Biotech CEO Council is a group of visionary CEOs from emerging biotech companies who meet regularly to connect, collaborate, and learn from each other. 

Emerging Biotech CEO Council

Drive commercial success through innovation and creativity

Who we are

Mission

Vision

Members

Brad Bailey

SVP & GM

GenMab

Dan Brennan

President & CEO

Alentia

Jeff Christensen

SVP Commercial

Assertio

Vic Clavelli

CCO

Optinose

Rich Daly

COO

CARsgen

Patrick Gallagher

CEO

Voltron

John Glasspool

CEO

Anthos Therapeutics

Kate Hermans

CEO

Ambrx

Ed Jordan

CCO

Humanigen

Sarah Liu

Chief Commercial Officer

9 Meters Biopharma

Sanjeev Luther

President & CEO

Cornerstone

Narasimhan Mani

President & CEO

Kesin

Shane Shaffer

CEO

Cingulate

Farrell Simon

SVP Comm & Strategy

Trevi Therapeutics

Vineet Singhal

COO

SGN

Raul Trillo

CCO

Vyluma